ArticleLeukemia2014

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis.

C P Venner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.